In rodents, infarct size after ischemia/reperfusion exhibits a circadian dependence on the time of coronary occlusion. It is not known if a similar circadian dependence of infarct size occurs in humans.
C ircadian rhythms exert a profound influence on cardiovascular physiology. 1 Heart rate, blood pressure, and many circulating hormones such as aldosterone and cortisol 2 follow a circadian pattern. In a similar manner, adverse cardiovascular events also demonstrate a time of day dependence with episodes of myocardial infarction, 3 sudden cardiac death, 4 and stent thrombosis 5 all peaking in the early morning hours. This time of day dependence mainly has been attributed to noncardiac factors such as changes in sympathetic tone 6 and circadian variation in coagulation factors. 7 Evidence has recently emerged indicating that circadian clocks intrinsic to cardiac cells may contribute to time of day dependence of cardiovascular physiology. Multiple clock proteins appear to be regulated in a time-dependent manner in cardiomyocytes that may have profound effects on myocardial metabolism, function, and response to injury. 8 In animal models, the disruption of these circadian clocks has been implicated in the pathogenesis of various cardiovascular diseases. 9 Recently, Durgan et al 10 demonstrated that ischemia/reperfusion tolerance is dependent on the time of day of coronary occlusion. Using a mouse ischemia/reperfusion model, they demonstrated a 3.5-fold variation in infarct size that was dependent on the time of day onset of coronary occlusion. They observed that the largest injury occurred at the sleep-to-wake transition, which translated into reduced left ventricular (LV) function when examined by echocardiography 1 month later. Furthermore, they demonstrated that the time of day variation in infarct size was abolished in a transgenic mouse with an ablated cardiomyocyte circadian clock.
We investigated if the phenomenon described by Durgan et al 10 occurs in humans by analyzing if the time of day onset at which the heart is subjected to ischemia influences subsequent infarct size and LV function in a cohort of patients with ST-segment elevation myocardial infarction (STEMI). and Western Wisconsin. 11 All STEMI patients who present to the referring hospitals are transferred to our institution for primary PCI regardless of time of presentation and no significant difference in pharmacological therapy or transfer times occur in those patients transferred at night versus day 12 (online Table I ). All patients had well-defined ischemic times and the data were supported by a subgroup with cardiac magnetic resonance imaging (cMRI) measurements of infarct size and area at risk (AAR). All medical records were reviewed by two of the authors blinded to time of presentation to ensure accuracy of the data.
A total of 1031 patients presented with STEMI and ischemic times between 1 and 6 hours. The ischemic time was defined as the time difference between the onset of chest pain to restoration of flow after the first balloon inflation during primary PCI. All patients were premedicated with aspirin (325 mg), clopidogrel (600 mg), heparin (60 U/kg), or bivalrudin (0.75 mg/kg bolus followed by 1.75 mg/kg/hr) and underwent routine PCI of the culprit vessel, with the majority of patients receiving drug-eluting stents.
A total of 866 patients were excluded from further analysis based on at least one of the following exclusion criteria ( Figure 1 ): thrombolysis in myocardial infarction flow Ͼ0 before coronary intervention or collateral filling of the infarct vessel (nϭ568); presence of preinfarction angina (nϭ94); previous coronary artery bypass graft or myocardial infarction in the same vascular distribution (nϭ72); cardiac arrest requiring Ͼ1 shock or cardiopulmonary resuscitation (nϭ70); peak of cardiac enzymes not recorded (nϭ44); postconditioning 13 performed during coronary intervention (nϭ10); vessel could not be opened (nϭ6); or acute stent thrombosis within 72 hours (nϭ2). A total of 165 patients (78% male; 59.5Ϯ12.7 years) with well-defined times of ischemia onset and duration (183Ϯ66 minutes) were included in the final analysis (Table) .
Measurement of Infarct Size and AAR by cMRI
A subgroup of 45 patients underwent cMRI measurements of infarct size and AAR within 3 days after STEMI. Infarct size was determined by delayed enhancement with gadolinium. Endocardial and epicardial borders were manually segmented from base to apex and infarct size was determined using the CIMRA software system (CSON Medical, www.csonmedical.com). AAR was estimated as the total amount of subendocardial surface area containing delayed enhancement as a percentage of the total subendocardial surface area. 14 Both infarct size and AAR were expressed as percentage of total LV mass.
The peak creatine kinase (CK) level was used as a surrogate of infarct size as previously described. [15] [16] [17] The validity of this assumption was also confirmed in the subgroup of patients in our cohort that underwent cardiac MRI, demonstrating a highly significant relationship between peak CK and delayed enhancement with gadolinium. Measurements of CK were performed on presentation and every 6 to 8 hours for 24 to 48 hours after reperfusion, with the highest value designated as the peak CK. Measurement of LV ejection fraction (LVEF) was obtained by echocardiography in 146 of the 165 patients within 48 hours after reperfusion.
Measurement of the Angiographic AAR
The angiographic AAR was calculated for each patient using the modified Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) score. 18 This method is based on previous pathological studies estimating the percentage of myocardium perfused by each coronary artery. For each patient, an AAR score, expressed as percentage of myocardium, was calculated based on the location of the culprit lesion in the infarct artery (proximal, mid, distal) in relation to major side branches and dominance of the vessel. This method has been previously validated by MRI measurements of AAR. 14
Statistical Analysis
The peak CK and LVEF for each patient were plotted against the time onset of ischemia expressed over a 24-hour interval. To determine if ischemic injury in the human heart is dependent on time of onset of infarction (circadian), a periodic sinusoidal regression analysis 19 was performed for both infarct size and LVEF using the online nonlinear regression web page (http://statpages.org/nonlin.html) using the following equation: f(t)ϭaϩb *sin(2 *(tϪc)/ 24) with "a" indicating the midline estimating statistic of rhythm, a measure of the rhythm-adjusted mean value, "b" indicating the amplitude, and "c" indicating the origin of the curve. A 24-hour period for circadian rhythm was assumed. Circadian rhythm was deemed to be present if the amplitude of the fitted curve was significantly different from 0 (Wald test).
Results

Peak CK as a Correlation to Infarct Size as Measured by cMRI
Multiple studies have previously demonstrated that peak CK is highly correlated with myocardial infarct size assessed by cMRI 15, 16 or single photon emission computed tomography. 17 As demonstrated in Figure 2 , there was excellent correlation between peak CK and infarct size by cMRI, which supports our use of peak CK as a surrogate of infarct size for the entire cohort (rϭ0.76; PϽ0.0001).
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Determination of the Circadian Dependence of Myocardial Infarct Size After STEMI
A significant association between time of onset of STEMI and myocardial infarct size as assessed by peak CK was demonstrated after nonlinear regression to a sinusoidal curve ( Figure 3 ). Maximal injury was observed at the time of day onset of chest pain at 1:00 AM. Amplitude of the sinusoidal curve was significantly different from 0 (PϽ0.0001), with the peak CK of the fitted curve approximately 82% higher compared to trough, suggesting a strong circadian influence. Similar results were obtained when peak troponin was used as a marker for myocardial damage (data not shown). A nearly identical relationship was observed when time of reperfusion was measured instead of onset of ischemia, with the curve being shifted to the right by 4 hours (5:00 AM). Because infarct size is significantly affected by the AAR, we plotted the AAR over the 24-hour cycle and found no variation ( Figure 4 ). Although intrahospital transfer times do not vary by time of day in our regionalized system, 12 symptom onset to emergency department presentation times may be delayed at night, potentially leading to longer ischemic times and myocardial injury. 20 However, as depicted in Figure 5 , ischemic times were relatively evenly distributed throughout the 24-hour day with no circadian relationship (Pϭ0.35), thereby excluding bias of myocardial injury by different ischemic times.
Correlation of Angiographic AAR to Measurements Obtained by cMRI
In the subgroup of patients with paired cMRI measurements, we confirmed that the angiographic method of the modified APPROACH score 18 was highly correlated with the AAR obtained by cMRI ( Figure 6 ; rϭ0.65; PϽ0.001). We then plotted the peak CK normalized by the angiographic AAR ( Figure 7A ) or AAR measured by cMRI ( Figure 7B ) against the time of onset of ischemia to demonstrate maintenance of a circadian relationship.
Assessment of Circadian Dependence of Left Ventricular Function After STEMI
LVEF was plotted against time of onset of infarction as a nonlinear (periodic) regression to a sinusoidal curve ( Figure 8 ) in 146 of the 165 patients who had LV function measurements performed within 48 hours after STEMI. Amplitude (LVEF) of the resulting curve was significantly different from 0 (PϽ0.03), demonstrating circadian influence with phase of the peak LVEF correlated with the trough of the peak CK curve (Figure 3 ). The absolute LVEF at peak was Ͼ7% higher than at trough (43% vs 51%).
Discussion
This study details one of the first descriptions in humans of a clear circadian distribution of myocardial infarct size in the setting of STEMI that is dependent on the time of coronary occlusion. The results are bolstered by a similar but time-shifted circadian pattern of the degree of LV dysfunction that results after myocardial infarction. These findings build on previous descriptions of circadian cardiovascular influences in humans such as onset of myocardial infarction 3 or sudden cardiac death. 4 However, whereas many previous descriptions are likely related to noncardiac circadian processes such as sympathetic tone 6 and coagulation factors, 7 recent animal studies 9,10 demonstrate circadian influences on transcriptional events in cardiomyocytes that may lead to varying degrees of myocardial protection throughout a 24-hour cycle. These preclinical observations and our findings may be relevant to clinical trials examining interventions to reduce infarct size because they demonstrate that the time of coronary occlusion will influence the subsequent degree of infarction. In agreement with the findings of Muller et al, 1 we did observe that the majority of STEMIs (31%) occurred between 6:00 AM and 12:00 PM in our level 1 patient population of Ͼ3000 subjects.
Many factors may ultimately affect final infarct size after prolonged ischemia. These include the occurrence of preinfarction angina 21 or presence of collateral blood flow to the dependent myocardial region, 22 among others, that may reduce infarct size for a given duration of ischemia and obscure potential circadian effects of myocardial protection based on the time of onset of ischemia. We carefully reviewed each chart and angiogram so that patients with these infarct-sparing mechanisms were excluded. Additionally, all patients had occluded arteries on presentation during their primary PCI so that the ischemic duration could be reasonably assessed.
We observed that the peak myocardial injury occurred at 1:00 AM when measured by time of symptom onset, and at 5:00 AM when measured by time of reperfusion. These findings are similar to those of De Luca et al, 23 who measured infarct size by enzyme analysis in 1548 consecutive patients with STEMI referred for primary PCI. By dividing the time of reperfusion into six 4-hour increments, they observed that the largest infarctions occurred between 4:00 AM and 8:00 AM, a time period that was associated with the highest platelet aggregation. Our data also correlate well with the data of Durgan et al, 10 who observed that peak myocardial injury occurred near the sleepto-wake transition in the nocturnal rodent after a 45-minute coronary occlusion. Our analysis of LV function also reveals that the greatest decrease in LV function occurred in those patients whose infarction began at approximately 1:00 AM, consistent with previous human data showing a peak incidence of congestive heart failure in those patients whose infarct began at night. 24 Studies from human cardiac tissue taken at the time of transplant surgery reveal significant circadian transcriptional variation in the principal cardiomyocyte clock genes, with PER1 and PER2 peaking in the morning and BMAL1 peaking in the evening. 8 modulate ischemia/reperfusion injury including Akt and glycogen synthase kinase-3b, which influences the opening of the mitochondrial permeability transition pore, the end-effecter of reperfusion injury. 25 In their study, the nadir of the phosphorylation status of Akt and glycogen synthase kinase-3b occurred at the time point of greatest myocardial injury and overall phosphorylation status of both proteins were linearly related to infarct size. In a secondary study, these findings were supported by observations in a circadian clock mutant mouse that is resistant to infarction because of chronic elevations in the phosphorylation status of these two proteins.
In a recent publication, Suarez-Barrientos et al 26 measured myocardial injury by peak CK or troponin-I in patients admitted to their institution with their first STEMI treated with primary PCI or fibrinolytic therapy. When they divided the presentation of symptom onset into four 6-hour blocks, they observed that the largest infarctions occurred when their onset of symptoms began between 6:00 AM and 12:00 PM, with a secondary peak between 12:00 PM and 6:00 PM. This is several hours later than our observations of peak myocardial injury. However, it is likely that significant differences in methodologies are relevant because no apparent effort was made to exclude patients with modifiers of infarct size such as collateral blood flow or preinfarction angina, and no measurements of AAR were performed to allow determination if a circadian tolerance to ischemia exists in the human heart.
Study Limitations
Our use of peak CK as a surrogate of infarct size to demonstrate a circadian injury response in the human heart in the setting STEMI warrants comment. The use of peak CK has been validated by multiple groups as an excellent estimate of infarct size 27 using different imaging modalities such as cMRI 15, 16 and single photon emission computed tomography. 17 Haase et al 15 prospectively measured infarct size with delayed contrastenhanced cMRI in 45 patients who underwent primary PCI for STEMI and observed a strong correlation between the absolute size of infarct (grams) and peak CK (rϭ0.72; PϽ0.001). Similar findings were also reported by Pride et al 16 in 78 patients with STEMI utilizing cMRI measurements of infarct size (rϭ0.93; PϽ0.001). In the EVOLVE trial, Chia et al 17 found that peak CK was highly correlated (rϭ0.73) with infarct size as determined by single photon emission computed tomography 5 days after primary PCI in 378 patients. Importantly, the subgroup of patients in our cohort with cMRI measurements of infarct size demonstrated excellent correlation with peak CK and had the same circadian relationship as obtained in the overall study cohort.
We have stipulated the onset of ischemia to be the onset of chest pain but recognize that in some patients this may not be the same time point, particularly if the patient was asleep when the infarction began. We cannot rule out that this may have produced a small effect on our data because the duration of ischemia would be longer and time of onset of ischemia would be shifted to an earlier time point. However, we did have access to all emergency department records where the patients initially presented and all subjects were interviewed the next day as part of our level 1 follow-up data collection program. Additionally, we have assumed that the occluded artery on presentation to the catheterization laboratory was closed throughout the entire duration of ischemia. Because the anticoagulation strategy was not controlled for in this cohort of patients, we cannot rule out that it may have had some small effect on the results of this investigation.
To rule out a possible selection bias of patients as a cause for our findings, we compared the baseline demographic data of patients in the circadian cohort versus all patients in the level 1 STEMI program admitted during the same time period (online Table I ). This analysis showed no important differences between groups except for age (59.5 vs 62.8 years), slightly greater Killips class 2 to 4 (10.4% vs 13.8%), and higher mortality in the overall STEMI population attributable to our prospective exclusion of cardiac arrest, previous bypass surgery, and myocardial infarction in the circadian group. Additionally, no important differences were observed between those patients admitted through our emergency department versus those transferred from outside hospitals (online Table II ).
Conclusions
Our findings demonstrate that humans display a circadian response to myocardial injury and LV function in the setting of STEMI. Maximal injury occurs when infarction begins in early morning hours and reperfusion occurs approximately 4 hours later, approaching the sleep-to-wake transition. These findings imply that there is a time-dependent mechanism of myocardial protection in the human heart that may have implications in clinical trials evaluating therapies to reduce infarct size in the setting of ischemia/reperfusion injury. Because this report is from a single center, these results should be confirmed in a larger, prospectively designed, multicenter trial with exclusive use of cMRI to measure infarct size and AAR.
